QI Activity: Pneumococcal Vaccination Recall Program for adults aged 70 years and older

24 February 2025

General practices are invited to register to participate in a Pneumococcal Vaccination Recall Program for adults aged 70 years and older, a simple QI activity to enhance patient care through a free patient recall initiative.

Program Success

Following on from the success of the program in 2024, this program is continuing to be funded by Pfizer, and offers a streamlined solution to increase the uptake of the National Immunisation Program (NIP) funded Pneumococcal vaccination in older adults. Practices can use this Pneumococcal QI template to record this as a quality improvement activity (QIA).

Program Benefits

• Simple Implementation: Activate the program within 24 hours with a secure software download and minimal staff time.
• Free Training and SMS Credits: Includes a 15-minute training session and all necessary SMS credits to implement the recall program.
• Improved Patient Health: Helps reduce the risk of hospitalisation by encouraging vaccination among older adults who are at higher risk of pneumococcal pneumonia.

How It Works

1. Complete Setup: GoShare will organise a time with you to complete setup of platform to enable free SMS.
2. Identify Eligible Patients: Use GoShare to send recall messages to patients aged 70 years and over who are eligible for the pneumococcal vaccine.
3. Personalised Patient Communication: Patients receive an SMS from your practice with a call to action to book an appointment, including a link to educational resources about pneumococcal pneumonia.

Why Participate? By participating in this program, your practice can play a crucial role in increasing vaccination rates and protecting the health of older adults in our community.

With only 1 in 3 Australians turning 71 in 2023 having received the NIP-funded 13vPCV vaccination by the end of 2023, there is a significant need to focus on adult vaccination efforts.

We encourage you to take advantage of this opportunity to provide your patients with essential protection against pneumococcal disease. To learn more about the program, please see the practice brief, or contact us at immunisation@cesphn.com.au.